Draft Guidance for Industry on Frequently Asked Questions About Medical Foods; Second Edition; Reopening of the Comment Period, 68460 [2013-27213]
Download as PDF
68460
Federal Register / Vol. 78, No. 220 / Thursday, November 14, 2013 / Notices
CDRH guidance documents is available
at https://www.fda.gov/MedicalDevices/
DeviceRegulationandGuidance/
GuidanceDocuments/default.htm.
Guidance documents are also available
at https://www.regulations.gov. To
receive ‘‘Medical Device Development
Tools,’’ you may either send an email
request to dsmica@fda.hhs.gov to
receive an electronic copy of the
document or send a fax request to 301–
847–8149 to receive a hard copy. Please
use the document number 1882 to
identify the guidance you are
requesting.
This draft guidance contains
information collection that is subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501–
3520). The collections of information in
21 CFR part 812 have been approved
under OMB control number 0910–0078;
the collections of information in 21 CFR
part 814 have been approved under
OMB control number 0910–0231; the
collections of information in 21 CFR
part 807 subpart E have been approved
under OMB control number 0910–0120;
and the collections of information in 21
CFR part 809 have been approved under
OMB control number 0910–0485.
V. Comments
Interested persons may submit either
electronic comments regarding this
document to https://www.regulations.gov
or written comments to the Division of
Dockets Management (see ADDRESSES). It
is only necessary to send one set of
comments. Identify comments with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday, and
will be posted to the docket at https://
www.regulations.gov.
[FR Doc. 2013–27233 Filed 11–13–13; 8:45 am]
TKELleY on DSK3SPTVN1PROD with NOTICES
BILLING CODE 4160–01–P
Food and Drug Administration
[Docket No. FDA–2013–D–0880]
Draft Guidance for Industry on
Frequently Asked Questions About
Medical Foods; Second Edition;
Reopening of the Comment Period
AGENCY:
Food and Drug Administration,
HHS.
Notice; reopening of the
comment period.
ACTION:
The Food and Drug
Administration (FDA or we) is
reopening the comment period for the
draft guidance for industry entitled
‘‘Frequently Asked Questions About
Medical Foods; Second Edition.’’ We are
reopening the comment period in
response to requests for an extension to
allow interested persons additional time
to submit comments.
DATES: Submit either electronic or
written comments by December 16,
2013.
SUMMARY:
IV. Paperwork Reduction Act of 1995
Dated: November 4, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Submit electronic
comments on the draft guidance to
https://www.regulations.gov. Submit
written comments to the Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Shawne Suggs-Anderson, Center for
Food Safety and Applied Nutrition
(HFS–850), Food and Drug
Administration, 5100 Paint Branch
Pkwy., College Park, MD 20740, 240–
402–1783.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
I. Background
In the Federal Register of August 13,
2013 (78 FR 49271), we published a
notice announcing the availability of an
updated draft guidance for industry
entitled ‘‘Frequently Asked Questions
About Medical Foods; Second Edition.’’
(We had published earlier versions of
the guidance in May 1997 and May
2007.) The draft guidance, when
finalized, will update some responses to
questions that appeared in earlier
versions of the guidance and add new
questions and responses regarding the
definition, labeling, and availability of
medical foods. We invited comment on
the draft guidance by October 15, 2013.
explained that they needed more time to
review the guidance, develop
comments, and assemble data.
If all of the guidance in the August 13,
2013, version were new, a reopening of
the comment period for 60 additional
days might be warranted. However,
much of the draft guidance remains
unchanged from our last revision in
2007. The additional content focuses on
FDA’s thinking relating to use of
medical foods under supervision by a
physician, whether medical foods
should be sold by prescription only, and
types of diseases and conditions that a
medical food could be used to manage.
We are, therefore, reopening the
comment period for the draft guidance
for an additional 30 days, until
December 16, 2013. We believe that this
reopening allows adequate time for
interested persons to submit comments
without significantly delaying further
FDA action on this draft guidance. (We
initially intended to extend the
comment period, but, due to the lapse
in appropriations and resulting
cessation of many government
operations from October 1 through
October 16, 2013, we were unable to
issue a notice extending the comment
period before October 15, 2013;
consequently, we are reopening the
comment period for an additional 30
days.)
III. How To Submit Comments
Interested persons may submit either
electronic comments regarding the draft
guidance to https://www.regulations.gov
or written comments to the Division of
Dockets Management (see ADDRESSES). It
is only necessary to send one set of
comments. Identify comments with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday, and
may be posted to the docket at https://
www.regulations.gov.
Dated: November 7, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013–27213 Filed 11–13–13; 8:45 am]
BILLING CODE 4160–01–P
II. Request for Comments
Following publication of the August
13, 2013, notice of availability, we
received requests for a 60-day extension
of the comment period. The requesters
VerDate Mar<15>2010
19:20 Nov 13, 2013
Jkt 232001
PO 00000
Frm 00051
Fmt 4703
Sfmt 9990
E:\FR\FM\14NON1.SGM
14NON1
Agencies
[Federal Register Volume 78, Number 220 (Thursday, November 14, 2013)]
[Notices]
[Page 68460]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-27213]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2013-D-0880]
Draft Guidance for Industry on Frequently Asked Questions About
Medical Foods; Second Edition; Reopening of the Comment Period
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; reopening of the comment period.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is reopening the
comment period for the draft guidance for industry entitled
``Frequently Asked Questions About Medical Foods; Second Edition.'' We
are reopening the comment period in response to requests for an
extension to allow interested persons additional time to submit
comments.
DATES: Submit either electronic or written comments by December 16,
2013.
ADDRESSES: Submit electronic comments on the draft guidance to https://www.regulations.gov. Submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Shawne Suggs-Anderson, Center for Food
Safety and Applied Nutrition (HFS-850), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park, MD 20740, 240-402-1783.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of August 13, 2013 (78 FR 49271), we
published a notice announcing the availability of an updated draft
guidance for industry entitled ``Frequently Asked Questions About
Medical Foods; Second Edition.'' (We had published earlier versions of
the guidance in May 1997 and May 2007.) The draft guidance, when
finalized, will update some responses to questions that appeared in
earlier versions of the guidance and add new questions and responses
regarding the definition, labeling, and availability of medical foods.
We invited comment on the draft guidance by October 15, 2013.
II. Request for Comments
Following publication of the August 13, 2013, notice of
availability, we received requests for a 60-day extension of the
comment period. The requesters explained that they needed more time to
review the guidance, develop comments, and assemble data.
If all of the guidance in the August 13, 2013, version were new, a
reopening of the comment period for 60 additional days might be
warranted. However, much of the draft guidance remains unchanged from
our last revision in 2007. The additional content focuses on FDA's
thinking relating to use of medical foods under supervision by a
physician, whether medical foods should be sold by prescription only,
and types of diseases and conditions that a medical food could be used
to manage. We are, therefore, reopening the comment period for the
draft guidance for an additional 30 days, until December 16, 2013. We
believe that this reopening allows adequate time for interested persons
to submit comments without significantly delaying further FDA action on
this draft guidance. (We initially intended to extend the comment
period, but, due to the lapse in appropriations and resulting cessation
of many government operations from October 1 through October 16, 2013,
we were unable to issue a notice extending the comment period before
October 15, 2013; consequently, we are reopening the comment period for
an additional 30 days.)
III. How To Submit Comments
Interested persons may submit either electronic comments regarding
the draft guidance to https://www.regulations.gov or written comments to
the Division of Dockets Management (see ADDRESSES). It is only
necessary to send one set of comments. Identify comments with the
docket number found in brackets in the heading of this document.
Received comments may be seen in the Division of Dockets Management
between 9 a.m. and 4 p.m., Monday through Friday, and may be posted to
the docket at https://www.regulations.gov.
Dated: November 7, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-27213 Filed 11-13-13; 8:45 am]
BILLING CODE 4160-01-P